Biotech and AI Lead the Charge in $100 Million Plus Funding Rounds
Biotech and artificial intelligence continue to dominate funding rounds with major investments; highlights include Candid Therapeutics raising $370 million and Glean securing $260 million, reflecting a strong market trend. Other …
Biotech and AI Lead the Charge in $100 Million Plus Funding Rounds Read More